Cerus reported $-9951000 in Operating Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Atrion ATRI:US USD 8.8M 2.22M
Cerus CERS:US USD -9951000 2.5M
Cytori Therapeutics CYTX:US USD -5572000 478K
Haemonetics HAE:US USD 43.28M 3.45M
Neogen NEOG:US USD -7656000 13.72M
Nuvasive NUVA:US USD 21.64M 127K
Orasure Technologies OSUR:US USD 13.43M 12.56M
Quidel QDEL:US USD 86.5M 29.7M
Rockwell Medical RMTI:US USD -3708000 774K
Sientra SIEN:US USD -12558000 3.38M
Staar Surgical STAA:US USD 964K 12.74M
Terumo 4543:JP JPY 37.54B 11.99B
Utah Medical Products UTMD:US USD 5.14M 84K